Stock listing
Dermata Therapeutics, Inc.
Selected listing: DRMA · NASDAQ · USD · US
Dermata Therapeutics, Inc. (NASDAQ:DRMA), Consumer Non-Durables. Latest release Aug 25, 2026: Dermata Therapeutics Announces Commercial Launch of Tome…
- Ticker
- NASDAQ:DRMA
- Asset type
- Stock
- Sector
- Consumer Non-Durables
- Industry
- Household/Personal Care
- Exchange
- NASDAQ
- Currency
- USD
About Dermata Therapeutics, Inc.
The company focuses on developing innovative therapies for skin conditions. Dermata aims to address unmet needs in dermatology through its research and development efforts.
Latest news from Dermata Therapeutics, Inc.
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
August 25, 2026
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 17, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
August 11, 2026
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
August 5, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
May 13, 2026
Research Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. company profile
View the public company page for Dermata Therapeutics, Inc. on 6ix.
Dermata Therapeutics, Inc. news
Read company news and market updates connected to Dermata Therapeutics, Inc..
Dermata Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Dermata Therapeutics, Inc..